Viral Vector Development MarketThe Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, ...

According to a new market research report, ' Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, ...

Cellevate has launched its Cellevat3d nanofiber-based cell culture systems. They are designed to enable faster bioprocessing, more efficient scale up, and more viral vector yield. Cellevate asserts ...

Previous efforts to circumvent the problem of the size limitation imposed by the AAV vector have focused mainly on altering the candidate genes into ‘mini-expression cassettes’ suitable for ...

The global viral vectors and plasmid DNA manufacturing market was valued at $918.37 million in 2019, and is estimated to reach at $4,978.54 million by 2027, registering a CAGR of ...

The Pan American Health Organization (PAHO) is urging its member states to strengthen surveillance as the vector-borne ...

Adds to Growing Portfolio of Intellectual Property AssetsATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a ...

GeoVax Labs (GOVX) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No. 17/876,682 ...